← Evidence map

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.

Chuandong Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

18 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37581614